Tommaso Ceruti

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

High Performance Liquid Chromatography

Acute Lymphoblastic Leukemia

Acute Respiratory Distress Syndrome

High Fat Diet Induced

Top Venues

Molecules (Basel, Switzerland)

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Tommaso Ceruti, Roberta Frapolli, Carmen Ghilardi, Alessandra Decio, Giulia Dellavedova, Sara Tommasi, Massimo Zucchetti, Arduino Aleksander Mangoni
Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in Mice. Molecules (Basel, Switzerland) 28 (24) (2023)
Tommaso Ceruti, Roberta Frapolli, Carmen Ghilardi, Alessandra Decio, Giulia Dellavedova, Sara Tommasi, Massimo Zucchetti, Arduino Aleksander Mangoni
Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in Mice. Molecules (Basel, Switzerland) 28 (24) (2023)
Tommaso Ceruti, Quintino Giorgio D'Alessandris, Roberta Frapolli, Jay Gopalakrishnan, Mariachiara Buccarelli, Marina Meroni, Liverana Lauretti, Lucia Ricci-Vitiani, Roberto Pallini, Massimo Zucchetti
Development and Validation of a HPLC-MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice. Pharmaceutics 14 (10) (2022)
Cristina Matteo, Antonella Colombini, Laura Rachele Bettini, Luca Porcu, Silvia Barzaghi, Tommaso Ceruti, Daniela Silvestri, Angela Amoroso, Fabiola Dell'Acqua, Giacomo Gotti, Claudia Nastasi, Massimo Zucchetti, Carmelo Rizzari
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase product. Pediatric blood & cancer 69 (9) (2022)